产品目录
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 24001 | Bomedemstat | 1990504-34-1 | ≧98.0% |  |
| Bomedemstat 是一种口服的、不可逆的赖氨酸特异性去甲基酶 1 (LSD1) | ||||
| 218701 | TOVINONTRINE ( IMR-687 ) | 2062661-53-2 | ≧98.0% | _2062661-53-2.gif) |
| TOVINONTRINE (IMR-687) 是一种高选择性和有效的磷酸二酯酶 9 (PDE9) 小分 | ||||
| 2073104 | Enarodustat ( JTZ-951 ) | 1262132-81-9 | 98% Min. | _1262132-81-9.png) |
| Enarodustat ( JTZ-951 ) is an orally-active HIF-PH inhibitor with an EC50 of 0.22 Μm | ||||
| 111895 | Oteseconazole | 1340593-59-0 | ≧98.0% |  |
| Oteseconazole，也称为 VT-1161，是第一个批准的口服生物利用度和选择 | ||||
| 17031303 | Tirabrutinib游离 ( ONO-4059 ) | 1351636-18-4 | ≧98.0% | _1351636-18-4.png) |
| Tirabrutinib，也被称为ONO- 4059，是在抑制剂中，一种强大的、具有口 | ||||
| 17012103 | ONO-4059盐酸盐 | 1439901-97-9 | ≧98.0% |  |
| ONO-4059是BTK的选择性和新型抑制剂，IC50为2.2 nm，ONO-4059与B细胞内的 | ||||
| 20258 | CRT0273750 | 1979939-16-6 | ≧98.0% |  |
| CRT0273750 modulates LPA levels in plasma and is suitable for in vivo studies. | ||||
| 20376 | TOFA ( RMI14514; MDL14514) | 54857-86-2 | ≧98.0% | -2-FUROIC_ACID_54857-86-2.png) |
| TOFA (RMI14514; MDL14514) 是乙酰辅酶A 羧化酶-α (ACCA) 的变构抑制剂。在 | ||||
| 20102901 | Razuprotafib | 1008510-37-9 | ≧98.0% |  |
| Razuprotafib，也称为AKB-9778，是血管内皮蛋白酪氨酸磷酸酶（VE-PTP） | ||||
| 2105071 | AP1189 acetate | 959850-74-9 | ≧98.0% |  |
| AP1189 is a melanocortin receptor agonist on MC1 and MC3 receptors. | ||||
| 20103003 | ML380 | 1627138-52-6 | ≧98.0% |  |
| ML380 is a highly potent and the first CNS penetrant M5 positive allosteric modulator | ||||
| 2071535 | Danicopan | 1903768-17-1 | ≧98.0% |  |
| Danicopan, aslo known as ACH-4471 and ACH-0144471, is a highly potent, orally active | ||||